Stifel Nicolaus analyst Shlomo Rosenbaum maintained a Buy rating on Clarivate (CLVT – Research Report) today and set a price target of $8.00.

Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced it has been recognized by Clarivate as the top-ranked medical technology company in the Top 100 Global ...

Get a taste of the exceptional research shared each month.

The increasing occurrence of chronic diseases is boosting the demand for advanced and effective treatments, highlighting the necessity for AI-powered drug commercialization. The expanding focus on ...

Include popular icons in your React projects easily with react-icons, which utilizes ES6 imports that allows you to include only the icons that your project is using. For example, to use an icon from ...

Clarivate PLC (NYSE:CLVT), a global leader in providing trusted insights and analytics with a market capitalization of $3.14 billion, is navigating through a period of significant transition. The ...

In this article, we are going to take a look at where Clarivate Plc (NYSE:CLVT) stands against the other technology stocks. Tracking insider buying activity can provide valuable insights into ...

If you’re on the fence about investing in Korn Ferry or Clarivate Plc because you’re not sure how they measure up, it’s important to compare them on a few factors before making your decision. Read on ...

Clarivate PLC (CLVT) came out with quarterly earnings of $0.21 per share, beating the Zacks Consensus Estimate of $0.20 per share. This compares to earnings of $0.23 per share a year ago.

(1) Reflects restructuring costs expected to be incurred in 2025 associated with the Value Creation Plan. (2) For the purposes of calculating adjusted diluted EPS, we have assumed the "if ...